EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation

Negar Paknia iD, Hadis Soltanimehr iD, Hadieh Rahbar Kafshboran iD, Soheila Ghasemi iD

ChemMedChem · 12.11.2026 · 21 (21)

DOI: 10.1002/cmdc.70552 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ChemMedChem, online erschienen am 05.11.2026. Verfasst von Negar Paknia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Sciences, Shiraz University, Shiraz, Iran. Hauptthemen laut MEDLINE: Hydrogels, Neoplasms, Antineoplastic Agents, Drug Design. Die Arbeit nennt 366 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimuli‐responsive hydrogels (SRHs) are versatile soft biomaterials capable of dynamically responding to environmental cues, enabling controlled and site‐specific drug release for cancer therapy. Advances in polymer chemistry and nanotechnology have facilitated the development of SRHs that respond to tumor‐associated stimuli, including pH, redox potential, temperature, enzymatic activity, light, and glucose gradients. Among these systems, pH‐ and redox‐responsive hydrogels exploit the acidic and oxidative tumor microenvironment, while thermo‐ and photo‐responsive platforms enable spatiotemporal regulation of therapeutic payloads. Recent studies have demonstrated highly efficient, stimulus‐triggered drug release and enhanced therapeutic outcomes in vitro and in vivo. This review systematically examines the design strategies, molecular mechanisms, and structure–function relationships governing SRHs in oncology. Emerging hydrogel architectures—such as injectable systems, hybrid nanocomposites, and multifunctional platforms integrating targeting or imaging capabilities—are critically discussed. Importantly, the review addresses key challenges in clinical translation, including biocompatibility, scalability, regulatory considerations, and reproducibility. Finally, future perspectives are outlined, highlighting the potential of artificial intelligence‐assisted material design, computational modeling, and wearable or implantable bioelectronic interfaces for real‐time monitoring and adaptive cancer therapy. By integrating mechanistic insights with translational and regulatory viewpoints, this review aims to guide the rational development of next‐generation smart hydrogel therapeutics for clinical oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HydrogelsNeoplasmsAntineoplastic AgentsDrug DesignHumansAnimalsTumor MicroenvironmentDrug Carriers

Stichwörter der Autor:innen

AI‐assisted hydrogel designcancer therapycontrolled drug deliverystimuli‐responsive hydrogelstumor microenvironment

Substanzen

HydrogelsAntineoplastic AgentsDrug Carriers

Autor:innen und Institutionen

  • Department of Chemistry, College of Sciences, Shiraz University, Shiraz, Iran.

ORCID-Profile: Negar Paknia, Hadis Soltanimehr, Hadieh Rahbar Kafshboran, Soheila Ghasemi

Zitieren

APA

Paknia, N., Soltanimehr, H., Kafshboran, H. R., & Ghasemi, S. (2026). Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation. ChemMedChem, 21(21). https://doi.org/10.1002/cmdc.70552

Vancouver

Paknia N, Soltanimehr H, Kafshboran HR, Ghasemi S. Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation. ChemMedChem. 2026;21(21). doi:10.1002/cmdc.70552

BibTeX
@article{Paknia2026,
  author = {Paknia, Negar and Soltanimehr, Hadis and Kafshboran, Hadieh Rahbar and Ghasemi, Soheila},
  title = {Stimuli‐Responsive Hydrogels for Cancer Therapy: Design Strategies, Mechanisms, and Challenges in Clinical Translation},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {21},
  doi = {10.1002/cmdc.70552}
}
Kostenlos starten →